PVWM
GSK icon

Point View Wealth Management’s GSK GSK Stock Holding History

Point View Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$254K Sell
5,517
-238
-4% -$10.9K 0.1% 223
2020
Q3 		$271K Buy
5,755
+130
+2% +$6.51K 0.13% 201
2020
Q2 		$287K Sell
5,625
-691
-11% -$35.5K 0.14% 192
2020
Q1 		$299K Sell
6,316
-683
-10% -$36.4K 0.16% 178
2019
Q4 		$411K Sell
6,999
-716
-9% -$39.8K 0.17% 175
2019
Q3 		$412K Sell
7,715
-1,743
-18% -$89.7K 0.19% 161
2019
Q2 		$473K Hold
9,458
– – 0.2% 147
2019
Q1 		$494K Sell
9,458
-302
-3% -$15.1K 0.22% 142
2018
Q4 		$466K Sell
9,760
-594
-6% -$29.3K 0.24% 133
2018
Q3 		$520K Buy
10,354
+648
+7% +$32.9K 0.23% 142
2018
Q2 		$489K Buy
9,706
+432
+5% +$21.8K 0.23% 144
2018
Q1 		$453K Buy
9,274
+345
+4% +$16.1K 0.22% 145
2017
Q4 		$396K Buy
8,929
+856
+11% +$39.5K 0.19% 157
2017
Q3 		$410K Buy
8,073
+987
+14% +$50.1K 0.2% 157
2017
Q2 		$382K Buy
7,086
+1,317
+23% +$70.2K 0.19% 159
2017
Q1 		$304K Buy
5,769
+656
+13% +$33.3K 0.16% 176
2016
Q4 		$246K Sell
5,113
-59
-1% -$2.91K 0.14% 184
2016
Q3 		$279K Sell
5,172
-82
-2% -$4.5K 0.17% 173
2016
Q2 		$285K Buy
5,254
+311
+6% +$16.4K 0.17% 168
2016
Q1 		$251K Buy
+4,943
New +$246K 0.16% 176

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Point View Wealth Management's GSK Position: Q4 2020 in Review

Point View Wealth Management reduced its GSK (GSK) stake by 4.1% in Q4 2020, selling an estimated $10.9K and leaving 5,517 shares worth $254K. The position accounts for 0.1% of the portfolio, ranked #223.

Point View Wealth Management first reported a position in GSK in Q1 2016 and has held it in 20 quarters since. The position peaked at $520K in Q3 2018. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Point View Wealth Management held 5,517 shares of GSK worth $254K as of Q4 2020.
  • Point View Wealth Management sold 238 GSK shares in Q4 2020, an estimated $10.9K.
  • GSK made up 0.1% of Point View Wealth Management's portfolio in Q4 2020, its #223 holding.
  • Point View Wealth Management first reported a position in GSK in Q1 2016 and has held it in 20 quarters since.
  • Point View Wealth Management's GSK position peaked at $520K in Q3 2018.
  • 819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.